Catherine Anastasopoulou, MD

Einstein Endocrine Associates
Philadelphia, United States

Disclosure information not submitted.

Presentation(s):

• MON-790 - Romosozumab Following Anabolic Therapy in Severe Osteoporosis: A Case Series

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT